Shikiar Asset Management Has Raised Starwood Property Trust (STWD) Holding; Granahan Investment Management Has Upped By $353,872 Its Ligand Pharmaceuticals (LGND) Stake

February 20, 2018 - By Vivian Park

Shikiar Asset Management Inc increased Starwood Property Trust Inc (STWD) stake by 53.23% reported in 2017Q3 SEC filing. Shikiar Asset Management Inc acquired 67,580 shares as Starwood Property Trust Inc (STWD)’s stock declined 5.55%. The Shikiar Asset Management Inc holds 194,550 shares with $4.23M value, up from 126,970 last quarter. Starwood Property Trust Inc now has $5.27 billion valuation. The stock increased 1.20% or $0.24 during the last trading session, reaching $20.24. About 1.52 million shares traded. Starwood Property Trust, Inc. (NYSE:STWD) has risen 8.65% since February 20, 2017 and is uptrending. It has underperformed by 8.05% the S&P500.

Granahan Investment Management Inc increased Ligand Pharmaceuticals (LGND) stake by 7.96% reported in 2017Q3 SEC filing. Granahan Investment Management Inc acquired 2,602 shares as Ligand Pharmaceuticals (LGND)’s stock rose 7.66%. The Granahan Investment Management Inc holds 35,272 shares with $4.80 million value, up from 32,670 last quarter. Ligand Pharmaceuticals now has $3.32B valuation. The stock decreased 0.03% or $0.04 during the last trading session, reaching $157.14. About 144,506 shares traded. Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) has declined 2.87% since February 20, 2017 and is downtrending. It has underperformed by 19.57% the S&P500.




Among 6 analysts covering Ligand Pharmaceuticals (NASDAQ:LGND), 5 have Buy rating, 1 Sell and 0 Hold. Therefore 83% are positive. Ligand Pharmaceuticals had 24 analyst reports since September 3, 2015 according to SRatingsIntel. H.C. Wainwright reinitiated the stock with “Buy” rating in Tuesday, September 5 report. Deutsche Bank maintained Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) on Monday, July 17 with “Hold” rating. Roth Capital maintained Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) on Friday, March 11 with “Buy” rating. The rating was maintained by Roth Capital with “Buy” on Thursday, September 3. The firm has “Buy” rating by H.C. Wainwright given on Thursday, October 5. The firm has “Buy” rating by Craig Hallum given on Wednesday, November 15. On Tuesday, August 8 the stock rating was maintained by Deutsche Bank with “Hold”. Roth Capital maintained the shares of LGND in report on Monday, September 21 with “Buy” rating. The rating was maintained by TH Capital on Friday, December 18 with “Buy”. Roth Capital maintained the stock with “Buy” rating in Monday, November 13 report.

Investors sentiment increased to 1.69 in Q3 2017. Its up 0.45, from 1.24 in 2017Q2. It improved, as 19 investors sold LGND shares while 68 reduced holdings. 50 funds opened positions while 97 raised stakes. 22.76 million shares or 0.86% more from 22.57 million shares in 2017Q2 were reported. Hood River Cap Management Lc accumulated 1.43% or 165,102 shares. Metropolitan Life Insur Co Ny reported 13,548 shares or 0.01% of all its holdings. Invesco Limited has 0.01% invested in Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) for 199,544 shares. Portfolio Solutions Ltd holds 50 shares. Pennsylvania-based Glenmede Tru Na has invested 0.19% in Ligand Pharmaceuticals Incorporated (NASDAQ:LGND). Convergence Prns Ltd Liability Co has invested 0.26% in Ligand Pharmaceuticals Incorporated (NASDAQ:LGND). 27,265 are held by Pnc Fincl Gru. Raymond James And Associate holds 0% or 8,752 shares in its portfolio. Goldman Sachs Grp Inc holds 265,683 shares or 0.01% of its portfolio. Moreover, State Of Alaska Department Of Revenue has 0.03% invested in Ligand Pharmaceuticals Incorporated (NASDAQ:LGND). Johnson Counsel holds 0.01% or 2,097 shares in its portfolio. Moreover, Assetmark has 0% invested in Ligand Pharmaceuticals Incorporated (NASDAQ:LGND). Price T Rowe Assocs Md reported 242,827 shares. Parsons Capital Mgmt Incorporated Ri holds 0.06% or 3,667 shares. Congress Asset Mgmt Ma has 14,855 shares for 0.03% of their portfolio.

Since August 23, 2017, it had 0 insider buys, and 6 insider sales for $10.58 million activity. Aryeh Jason sold $255,980 worth of stock. On Wednesday, January 24 HIGGINS JOHN L sold $3.71 million worth of Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) or 22,500 shares. KOZARICH JOHN W sold $362,500 worth of stock. 925 Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) shares with value of $126,956 were sold by Sabba Stephen L.

Granahan Investment Management Inc decreased Qts Realty Trust (NYSE:QTS) stake by 40,549 shares to 42,745 valued at $2.24 million in 2017Q3. It also reduced Instructure stake by 48,642 shares and now owns 206,741 shares. Veeva Systems (NYSE:VEEV) was reduced too.

Shikiar Asset Management Inc decreased Colony Northstar Inc. Cl A stake by 141,429 shares to 369,518 valued at $4.64M in 2017Q3. It also reduced Thl Credit Inc (NASDAQ:TCRD) stake by 35,820 shares and now owns 282,505 shares. Kite Pharma Inc (NASDAQ:KITE) was reduced too.

Among 10 analysts covering Starwood Property Trust Inc. (NYSE:STWD), 7 have Buy rating, 0 Sell and 3 Hold. Therefore 70% are positive. Starwood Property Trust Inc. had 25 analyst reports since August 5, 2015 according to SRatingsIntel. On Friday, August 7 the stock rating was maintained by Deutsche Bank with “Buy”. As per Thursday, November 9, the company rating was maintained by FBR Capital. Keefe Bruyette & Woods maintained the stock with “Buy” rating in Wednesday, August 9 report. As per Friday, February 26, the company rating was maintained by FBR Capital. As per Monday, September 26, the company rating was maintained by Credit Suisse. The firm earned “Neutral” rating on Monday, August 15 by Compass Point. Goldman Sachs downgraded Starwood Property Trust, Inc. (NYSE:STWD) rating on Wednesday, January 13. Goldman Sachs has “Neutral” rating and $22.50 target. The company was maintained on Monday, November 27 by FBR Capital. The rating was downgraded by Bank of America to “Neutral” on Thursday, December 15. The stock has “Buy” rating by Keefe Bruyette & Woods on Thursday, September 14.

Since September 19, 2017, it had 0 insider buys, and 2 insider sales for $398,066 activity. Sossen Andrew Jay sold 11,270 shares worth $247,267. Shares for $150,799 were sold by Paniry Rina on Tuesday, September 19.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: